{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T17:12:00Z","timestamp":1747761120167},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,26]]},"DOI":"10.7759\/cureus.32963","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T17:01:08Z","timestamp":1672074068000},"source":"Crossref","is-referenced-by-count":4,"title":["Cycloserine-Induced Insomnia and Psychosis in Multidrug-Resistant Pulmonary Tuberculosis - A Case Report"],"prefix":"10.7759","author":[{"given":"Sankalp","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. global tuberculosis report 2022. (2022). Accessed: December 20, 2022: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.08.002","article-title":"Treatment of drug-resistant tuberculosis","volume":"40","author":"Mase SR","year":"2019","unstructured":"Mase SR, Chorba T. Treatment of drug-resistant tuberculosis. Clin Chest Med. 2019, 40:775-95. 10.1016\/j.ccm.2019.08.002","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.11604\/pamj-cm.2019.1.25.20904","article-title":"Adverse drug reactions due to cycloserine on the central nervous system in the multidrug-resistant tuberculosis cases: a case series","volume":"1","author":"Yadav S","year":"2019","unstructured":"Yadav S, Rawal G. Adverse drug reactions due to cycloserine on the central nervous system in the multidrug-resistant tuberculosis cases: a case series. PAMJ - Clinical Medicine. 2019, 1:25. 10.11604\/pamj-cm.2019.1.25.20904","journal-title":"PAMJ - Clinical Medicine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.153439","article-title":"Cycloserine induced psychosis with hepatic dysfunction","volume":"47","author":"Tandon VR","year":"2015","unstructured":"Tandon VR, Rani N, Roshi, Gupta R, Arora M, Khajuria V, Mahajan V. Cycloserine induced psychosis with hepatic dysfunction. Indian J Pharmacol. 2015, 47:230-1. 10.4103\/0253-7613.153439","journal-title":"Indian J Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03300-2020","article-title":"World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update","volume":"57","author":"Mirzayev F","year":"2021","unstructured":"Mirzayev F, Viney K, Linh NN, et al.. World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update. Eur Respir J. 2021, 57:10.1183\/13993003.03300-2020","journal-title":"Eur Respir J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0972-6748.123636","article-title":"Cycloserine induced mania","volume":"22","author":"Bakhla AK","year":"2013","unstructured":"Bakhla AK, Gore PS, Srivastava SL. Cycloserine induced mania. Ind Psychiatry J. 2013, 22:69-70. 10.4103\/0972-6748.123636","journal-title":"Ind Psychiatry J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.12.0863","article-title":"Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis","volume":"17","author":"Hwang TJ","year":"2013","unstructured":"Hwang TJ, Wares DF, Jafarov A, Jakubowiak W, Nunn P, Keshavjee S. Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis. Int J Tuberc Lung Dis. 2013, 17:1257-66. 10.5588\/ijtld.12.0863","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-201469","article-title":"Antitubercular drug-induced violent suicide of a hospitalised patient","volume":"2014","author":"Behera C","year":"2014","unstructured":"Behera C, Krishna K, Singh HR. Antitubercular drug-induced violent suicide of a hospitalised patient. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2013-201469","journal-title":"BMJ Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.32.2.172","article-title":"Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis","volume":"32","author":"Lewis WC","year":"1957","unstructured":"Lewis WC, Calden G, Thurston JR, Gilson WE. Psychiatric and neurological reactions to cycloserine in the treatment of tuberculosis. Dis Chest. 1957, 32:172-82. 10.1378\/chest.32.2.172","journal-title":"Dis Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(99)00014-7","article-title":"D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study","volume":"21","author":"van Berckel BN","year":"1999","unstructured":"van Berckel BN, Evenblij CN, van Loon BJ, et al.. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study. Neuropsychopharmacol. 1999, 21:203-10. 10.1016\/S0893-133X(99)00014-7","journal-title":"Neuropsychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(89)90379-0","article-title":"D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics","volume":"98","author":"Hood WF","year":"1989","unstructured":"Hood WF, Compton RP, Monahan JB.  D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett. 1989, 98:91-5. 10.1016\/0304-3940(89)90379-0","journal-title":"Neurosci Lett"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00813745","article-title":"D-Cycloserine: agonist turned antagonist","volume":"6","author":"Lanthorn TH","year":"1994","unstructured":"Lanthorn TH. D-Cycloserine: agonist turned antagonist. Amino Acids. 1994, 6:247-60. 10.1007\/BF00813745","journal-title":"Amino Acids"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbs012","article-title":"D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia","volume":"38","author":"Goff DC","year":"2012","unstructured":"Goff DC. D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia. Schizophr Bull. 2012, 38:936-41. 10.1093\/schbul\/sbs012","journal-title":"Schizophr Bull"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.1.21","article-title":"A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia","volume":"56","author":"Goff DC","year":"1999","unstructured":"Goff DC, Tsai G, Levitt J, et al.. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry. 1999, 56:21-7. 10.1001\/archpsyc.56.1.21","journal-title":"Arch Gen Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.03.001","article-title":"Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis","volume":"105","author":"Court R","year":"2021","unstructured":"Court R, Centner CM, Chirehwa M, et al.. Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis. Int J Infect Dis. 2021, 105:688-94. 10.1016\/j.ijid.2021.03.001","journal-title":"Int J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.03.009","article-title":"Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis","volume":"36","author":"Sharma B","year":"2014","unstructured":"Sharma B, Handa R, Nagpal K, Prakash S, Gupta PK, Agrawal R. Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis. Gen Hosp Psychiatry. 2014, 36:451. 10.1016\/j.genhosppsych.2014.03.009","journal-title":"Gen Hosp Psychiatry"},{"key":"ref17","unstructured":"Guidelines for programmatic management of drug-resistant tuberculosis in India. (2021). Accessed. December 20, 2022: https:\/\/tbcindia.gov.in\/showfile.php?lid=3590."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/130262-cycloserine-induced-insomnia-and-psychosis-in-multidrug-resistant-pulmonary-tuberculosis---a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:41Z","timestamp":1707508121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/130262-cycloserine-induced-insomnia-and-psychosis-in-multidrug-resistant-pulmonary-tuberculosis---a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.32963","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,26]]}}}